Seems there are 17,669 s'holders subscribing for $10 million in capital - that's $566 (1132 shares) each. Don't know whether it's worth the admin cost of subscription. Might be better to wait for a correction and buy into that.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025